De-novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma.
about
Immune-Signatures for Lung Cancer Diagnostics: Evaluation of Protein Microarray Data Normalization Strategies.Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma.Unclassified renal cell carcinoma: a clinicopathological, comparative genomic hybridization, and whole-genome exon sequencing study.Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer.Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis.Natural humoral immune response to ribosomal P0 protein in colorectal cancer patientsAutoantibodies against tumor-associated antigens for detection of hepatocellular carcinomaAutoimmune response to PARP and BRCA1/BRCA2 in cancerAutoantibodies directed to centromere protein F in a patient with BRCA1 gene mutation.Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis.Expression of IGF-II in early experimental hepatocellular carcinomas and its significance in early diagnosis.Tumor-associated antigen arrays for the serological diagnosis of cancer.Mini-array of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of hepatocellular carcinoma.Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinomaUsing immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis.Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.A systematic review of humoral immune responses against tumor antigens.Serum autoantibodies as biomarkers for early cancer detection.Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors.Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC).Immunohistochemical analysis of centromere protein F expression in buccal and gingival squamous cell carcinoma.Anti-CENP-B antibodies are associated with prolonged survival in breast cancer.p62 Expression in primary carcinomas of the digestive system.Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization.Optimizing peptide epitope-based autoantibody detection in cancer patients.Serum levels of anti-sperm-associated antigen 9 antibody are elevated in patients with hepatocellular carcinoma.
P2860
Q31126986-99092DE1-207A-489A-BD8A-C96ED224CEA0Q33493776-070DD022-569C-4FC7-9DE6-27C6C919F26CQ34028996-F57C06E3-BE70-4C87-8EBF-9697167AF2E3Q34138916-862D86BF-CE85-4216-9C86-B7CCD3080C46Q35059164-D55B8630-E8BC-4F3A-9D35-32E7AF307D64Q35544786-36AEE77F-BCBA-47C3-8B3B-3FC7433A3AC6Q35715964-4FAF92DE-9718-4E79-B575-84B586C75922Q35793861-8E540E93-ACDF-4257-9E5A-12D69525EEB5Q35921496-8D0484F6-5998-4A2D-AE42-D75793C9B41DQ36169087-D34B0975-7E56-4DF5-9DD2-FDBE6E76AFC8Q36178311-4D3D6ED8-AAE2-4914-8C2A-9E2D15CB9084Q36491988-2E7A4F9B-9BFC-4E74-AE82-9EDBCFF0BF92Q36731844-BB179CA0-7FCC-402B-BC09-0C2DA7338814Q37187763-43E9B326-7346-47E5-AC6F-9B1255887659Q37213540-0EDEF117-72CC-403E-A619-9C8E6D34996EQ37252915-9937FA44-FD31-4726-8F9B-2C9FD07A2363Q37435862-59574FAF-7D7F-436E-8498-330575007823Q37622471-AFCD27CC-756A-4BCB-999A-A70BA37EE143Q37724875-0E640F62-C57C-4D6D-BBB4-94AC3459D9CCQ38107971-197D0B35-B300-4344-92FA-77F34E493E61Q38449298-B8395F26-937A-407F-8191-238415581A8BQ39892818-01D37D6D-D3D0-4FCA-A4EC-42E7EC47AFD0Q42113747-35C93AD6-F561-4A85-AB7E-26032251120EQ42835415-0628F81B-25FD-4490-87D6-C3D1B517ED05Q46190333-34F4A9B4-AE4C-4329-93C1-5E6DD3AF54FFQ47552142-3F70FB98-6F7A-43D5-AD71-810D234DFB2E
P2860
De-novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
De-novo humoral immune respons ...... e to hepatocellular carcinoma.
@ast
De-novo humoral immune respons ...... e to hepatocellular carcinoma.
@en
type
label
De-novo humoral immune respons ...... e to hepatocellular carcinoma.
@ast
De-novo humoral immune respons ...... e to hepatocellular carcinoma.
@en
prefLabel
De-novo humoral immune respons ...... e to hepatocellular carcinoma.
@ast
De-novo humoral immune respons ...... e to hepatocellular carcinoma.
@en
P2093
P2860
P1476
De-novo humoral immune respons ...... e to hepatocellular carcinoma.
@en
P2093
P2860
P356
10.1046/J.1365-2249.2001.01585.X
P577
2001-07-01T00:00:00Z